IBRX Stock Eyes Worst Week In Nearly 2 Years — But Anktiva’s Sepsis Trial Potential Fuels Retail Bets On Big Pharma Appeal
Founder Patrick Soon-Shiong said sepsis trials would begin soon in the U.S. and Europe.
Founder Patrick Soon-Shiong said sepsis trials would begin soon in the U.S. and Europe.